Infusion therapy for rheumatoid arthritis delivers biologic medications directly into your bloodstream through an IV line. These are engineered drugs that target specific parts of the immune system driving joint inflammation and damage, and they’re typically recommended when standard oral medications haven’t controlled your symptoms well enough. Sessions range from about 30 minutes to over two hours depending on the drug, and most people receive them at an outpatient infusion center every few weeks to every few months.
How Infused Biologics Work
Rheumatoid arthritis causes the immune system to attack healthy joint tissue, and specific immune signals drive that process. Infused biologics are designed to intercept those signals at precise points. Rather than broadly suppressing the immune system the way older drugs do, each biologic blocks a particular molecule or cell type responsible for inflammation.
The most commonly targeted molecule is TNF-alpha, a protein that triggers inflammation when it binds to receptors on cells in and around the joints. Drugs like infliximab (Remicade) are antibodies that latch onto TNF-alpha and prevent it from reaching those receptors, which slows the cascade of swelling, pain, and tissue erosion. Another target is IL-6, a different inflammatory signal. Tocilizumab (Actemra) blocks the receptor that IL-6 binds to, cutting off another major driver of joint damage. A third approach targets B-cells, a type of white blood cell involved in the autoimmune attack. Rituximab (Rituxan) binds to a marker on the surface of these cells and depletes them from circulation. Finally, abatacept (Orencia) works by blocking the activation signal that T-cells need to launch an immune response in the first place.
Common Infusion Medications
Four biologic drugs are most frequently given by IV infusion for rheumatoid arthritis:
- Infliximab (Remicade): a TNF-alpha blocker, also available as biosimilars such as Inflectra, Renflexis, and Avsola
- Tocilizumab (Actemra): an IL-6 inhibitor
- Rituximab (Rituxan): a B-cell depleting agent, with biosimilars including Truxima and Ruxience
- Abatacept (Orencia): a T-cell costimulation blocker
Most of these are prescribed alongside methotrexate, a standard oral medication for RA, because the combination tends to work better than either drug alone. Your rheumatologist will choose a specific biologic based on your disease severity, which treatments you’ve already tried, and your overall health profile. If one biologic doesn’t produce enough improvement, switching to a drug that targets a different part of the immune system is common.
What Happens During a Session
Infusion sessions take place in an outpatient infusion center, a hospital infusion suite, or occasionally at home with a visiting nurse. You’ll sit in a reclining chair while a nurse places an IV line, usually in your arm. The medication is then dripped slowly into your vein over a set period.
How long you sit there depends on the drug. In a real-world study of RA patients, infliximab infusions averaged about two hours of total infusion time, while golimumab (another TNF blocker given by IV) took roughly 30 minutes. Clinic visit duration, including check-in, setup, and the observation period afterward, added more time on top of that. Infliximab visits averaged about two and a half hours total, while shorter infusions brought the full visit closer to one hour.
Before the infusion starts, you may receive premedication to reduce the chance of a reaction. This commonly includes a corticosteroid to tamp down inflammation, an antihistamine to prevent histamine-driven symptoms like flushing or hives, and sometimes an antipyretic for fever prevention. These are given orally or through the IV line and typically add only a few minutes to the process.
Nurses monitor your vital signs throughout the session and for a short window afterward, especially during your first few infusions when reactions are most likely to occur. Frequency varies by medication. Some infusions happen every four to eight weeks once you’re on a maintenance schedule; rituximab courses are spaced further apart, often every six months.
Screening Before You Start
Because biologics suppress parts of your immune system, you’ll need several tests before your first infusion. The American College of Rheumatology and European guidelines both recommend screening for latent tuberculosis before starting any biologic. This is done with a blood test called an interferon-gamma release assay (or a tuberculin skin test), followed by a chest X-ray if results are positive. TB that’s been dormant in your body can reactivate when the immune system is suppressed, so identifying and treating it beforehand is essential.
You’ll also be tested for hepatitis B and hepatitis C. Hepatitis B screening checks for active infection and for antibodies that indicate past exposure, since the virus can reactivate under immunosuppression. Hepatitis C screening looks for antibodies as well. These tests are standard even in countries where these infections are uncommon, because the consequences of missing them are serious.
Side Effects and Infection Risk
The most immediate concern is an infusion reaction, which can happen during or shortly after the drip. Mild reactions include flushing, itching, headache, or a brief drop in blood pressure. Severe reactions are rare but can involve difficulty breathing or significant swelling. This is why first infusions are given slowly and under close monitoring, and why premedication is standard for certain drugs.
The bigger long-term risk is infection. Biologics work by dampening immune activity, which inherently lowers your ability to fight off bacteria and viruses. When a TNF-alpha blocker is added to methotrexate, about 5 in 100 people develop a serious infection over a year, compared to about 3 in 100 on methotrexate alone. That’s a modest absolute increase of 2 additional people per 100, but it matters. The risk is higher if you also have diabetes, chronic lung disease, or take corticosteroids alongside your biologic.
RA itself raises infection risk independently, which makes it harder to separate the disease’s effect from the drug’s effect. Still, your care team will monitor your bloodwork regularly and may postpone an infusion if you have an active infection.
Infusion Centers vs. Home Infusion
Most people start infusion therapy at a clinic or hospital outpatient center. Some eventually transition to home infusion, where a nurse comes to your house to administer the drug. Home infusion is more convenient, but the tradeoff is reduced oversight.
Research on patients receiving biologic infusions found that those treated at home were significantly more likely to experience adverse outcomes, including stopping therapy or needing emergency room visits, compared to those who continued at a clinic. Home infusion patients had 30% ER visit rates versus about 7% for clinic-based patients. The likely explanation: home patients had fewer clinic visits and fewer lab tests in the year following their switch, meaning problems were caught later. If you’re considering home infusion, it’s worth understanding that consistent monitoring, through regular bloodwork and check-ins, plays a real role in keeping treatment on track.
What Results to Expect
Biologics don’t work overnight. Most people notice gradual improvement in joint pain, stiffness, and swelling over the first several weeks to months. Some drugs, particularly TNF blockers, can produce noticeable relief within the first few infusion cycles. Others, like rituximab, may take longer because the B-cell depletion process unfolds over weeks. Your rheumatologist will typically reassess your response after three to six months to determine whether the drug is working well enough or whether switching to a different biologic makes more sense.
The goal isn’t just symptom relief. Biologics aim to slow or halt the joint erosion that causes permanent damage in RA. For many people, infusion therapy achieves low disease activity or remission when earlier treatments couldn’t. Staying on a consistent schedule matters, since skipping or delaying infusions can reduce the drug’s effectiveness and, in some cases, trigger your immune system to develop antibodies against the medication itself, making it less effective over time.